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Melk and Vienna, Austria
Objective: The purpose of this retrospective study was to present 7 years of data from operations of currently active,
chronic venous leg ulcers (CEAP: C6), focusing on the short- and long-term effects of healing and recurrence and
considering concomitant risk factors.
Methods: Between January 1997 and March 2004, 173 patients (239 legs) with a currently active, chronic venous leg
ulcer were surgically treated. The surgical procedures included two main steps: (1) the surgical interruption of reflux
in the superficial and perforating veins to reduce venous hypertension in the entire leg and/or the affected area and (2)
the surgical procedure involving the ulcer. A total of 123 patients (173 legs) who came to the follow-up were examined.
The follow-up period ranged from 3 months to 7 years. The data collection integrated a preoperative examination that
included medical history and clinical diagnoses and incorporated measurements such as body mass index, ankle-brachial
pressure index, and the neutral position method at the follow-up. The function of the veins was measured with duplex
ultrasonography. Finally, the data were analyzed by using various statistical methods, including Kaplan-Meier analysis,
Cox regression analysis, and paired t tests.
Results: Initially, ulcer healing occurred in 87% of the cases (151 legs). A total of 13% (22 legs) of the venous ulcers never
healed, and recurrent venous ulcers occurred in 5% (9 legs). The Kaplan-Meier analyses of ulcer healing showed a healing
rate of 85% in 6 months for all legs. The mean time of healing was 1.5 months. Furthermore, the Kaplan-Meier analyses
of ulcer recurrence showed a 1.7% rate of recurrence in 6 months for all legs. The 5-year ulcer recurrence rate was 4.6%.
The mean time of recurrence was 70.4 months.
Conclusions:On the basis of the results from the 7 years of data from functional surgery of venous leg ulcers and as a result
of the outcomes of our study, we recommend surgical treatment of venous leg ulcers at any stage. We therefore conclude
that surgery is indicated before an ulcer is intractable to treatment. In general, our findings are based on the
understanding and identification of the causes and symptoms of venous ulceration and illustrate that standard surgical
methods can be applied for the therapy of venous leg ulcers at any stage. (J Vasc Surg 2006;44:572-9.)Venous leg ulcers are the most serious type of chronic
venous incompetence.1 The prevalence of healed and active
leg ulcers is approximately 1% of the adult population in
Western countries,2 and an estimated 1% of total health
costs in the Western world result from the therapy costs of
chronic leg ulcers.3 Nelzen4 defined the ideal benefit for a
patient with a leg ulcer as the complete healing of the ulcer
in the shortest possible time at a low frequency of dressing
changes, associated with an adequate quality of life and no
recurrence. Various methods, such as compression treat-
ment, wound dressing materials, and surgical modalities,
are used for venous leg ulcer therapy.5
A wide variety of different surgical intervention ap-
proaches has been proposed. The Effect of Surgery and
Compression on Healing and Recurrence (ESCHAR)6
study illustrated that there is no significant difference in
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572healing time and healing rate between superficial venous
surgery plus compression and compression alone. How-
ever, the 12-month recurrence rate in the study was con-
siderably lower for patients treated with surgery. Zamboni
et al7 found similar results. The ESCHAR study6 empha-
sized that 85% of the patients with chronic venous leg ulcers
would benefit from surgery. In a recent study, Danielsson
et al8 advocated surgery in most patients with chronic leg
ulcers.
Up to now, compression therapy was considered the
basic treatment in venous leg ulcers. Its value has been
clearly demonstrated in several randomized controlled tri-
als and systematic reviews.9 Nelzen10,11 reported that com-
pression regimens help to heal ulcers in many cases but
often do not satisfactorily solve the problem of recurrence.
We report experiences and results from a retrospective
analysis of a 7-year period of operations, focusing on heal-
ing time, recurrence, and concomitant risk factors of leg
ulcers treated surgically.
PATIENTS AND METHODS
Patients. Between January 1997 and March 2004,
173 patients (239 legs) with a currently active, chronic
venous leg ulcer (CEAP: C6) were surgically treated by a
single surgeon. Patients with a healed ulcer (CEAP: C5)
who were surgically treated during the same period of time
were not included in these analyses.12 Because patients
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patient population was preselected. In our cases, previous
alternative treatments had failed, and all patients were
referred by phlebologists or by other hospitals. In the
absence of contraindications, surgery was performed in
every case. Consequently, this study focuses on a surgical
approach.
All patients were invited to a follow-up between March
and June 2004, as shown in Fig 1. The follow-up rate was
approximately 72%, thus allowing examination of 173 legs
(123 patients). More than half of the limbs lost to follow-
up were due to unrelated death.
The patient group characteristics were as follows: 42
men and 131 women, with a mean age of 66 years at the
time of the operation, ranging from 25 to 88 years (median,
67.42 years). The time between operation and follow-up
ranged between 3months and 7 years (median, 3.11 years).
In addition, the patient population included patients with
arterial diseases (mixed ulcers), which were treated at the
operation like venous ulcers.
Methods. Presurgical and postsurgical parameters were
compared to evaluate the success of the surgical therapy and to
describe different risk factors.13 Immediately after surgery, all
patients were supplied as described in “Surgical Procedures”
and documented until complete wound healing. These data
from just after surgery address the healing time.The follow-up
data show the long-term results with a focus on recurrence.
Information about the duration of ulceration and fam-
ily history was obtained in interviews. All legs were pho-
todocumented before surgery and at follow-up. Ulceration
size was quantified manually by planimetry. The grade of
sclerosis of the tissue around the ulcer was described ac-
cording to dermatoliposclerosis, including the fascia, pal-
pable calcification, or both.
The ankle-brachial pressure index was measured with a
bidirectional Doppler scan (SONODOP 3000, ELCAT;
Sonotechnik GmbH, Germany). Indices of 0.8 and lower
were taken as a sign of peripheral arterial disease (PAD).14
The range of movement of the ankle joint was described by
the neutral position method.15 Starting from dorsiflexion
over the neutral position to plantar flexion, free mobility of
239 legs 
(52 PAD) 
surgically treated 
between 1997 and 2004 
29 no follow-up 
(5 PAD) 
173 follow-up 
(30 PAD) 
37 died 
(17 PAD) 
142 healed 9 recurrent 22 non-healed 
Fig 1. Trial profile. PAD, Peripheral arterial disease.the ankle joint was indicated by 15°-0°-40°, restrictedmobility by 10°-0°-40°, excessively restricted mobility by
0°-10°-40°, and stiffness by a contraction in the plantar-
flexed position.
The grade of edema was described on a score from 0
(no edema) to 3 (severe edema) according to the venous
clinical severity score.16 Allergic reactions to topical appli-
cations were verified by previous patch tests of 95 legs.17
Obesity was characterized by the body mass index
(BMI). A BMI less than 19 kg/m2 was defined as under-
weight, 19 to 24.9 kg/m2 was considered normal, from 25
to 29.9 kg/m2 was considered overweight, and 30 kg/m2
or above was classified as obese.
Duplex scanning. Reflux in the superficial, deep, and
perforator veins was evaluated with duplex ultrasound scan-
ning (TITAN; SonoSite, Bothell, Wash) in the standing
position to define the anatomy and pathophysiology of the
venous insufficiency according to the CEAP system.12
The Valsalva maneuver was used to evaluate saphe-
nofemoral and femoroiliac reflux. To evaluate the saphe-
nofemoral reflux, the popliteal vein, and the perforators,
manual compression and release of the calf or foot were
used. Reflux time exceeding 0.5 seconds was considered
pathologic.18 Additionally, the reflux routes were detected
directly by soft manual compression and release of the
ulcerated area. During the duplex examination, no ex-
tended systematic search was performed for venous ob-
structions or remnants of venous obstructions in the deep
veins.
Quality of life. Suitable diagnostic tools such as the
Nottingham Health Profile,19 the visual analogue scale,20
and the grade of subjective health (on a score from 1 [very
good] to 5 [very bad]) were used to determine health-
related quality of life before the surgery and at follow-up.
Surgical procedures. There were two surgical goals.
The first goal was to abolish venous refluxes in the superfi-
cial and perforating veins as detected and marked by duplex
scan to reduce venous hypertension in the affected area or
the entire leg. To accomplish this goal, surgery of the great
saphenous vein, the short saphenous vein, and/or surgery
of the perforator veins was performed (Fig 2). No surgery
of deep veins was performed.
Surgery of the great saphenous vein. Ligation of the
saphenofemoral junction, selective partial stripping of the
incompetent great saphenous vein by invagination from
groin to knee, and minisurgical phlebectomy of bigger side
branches were performed.
Surgery of the short saphenous vein. Ligation of the
saphenopopliteal junction, selective partial stripping of the
incompetent short saphenous vein by invagination from
knee to the calf, and minisurgical phlebectomy of bigger
side branches were performed.
Surgery of the perforator veins. Open ligation, sub-
fascial endoscopic perforator vein surgery (SEPS), and di-
rect ligation in case of fasciectomy during preparation were
performed.
These were followed by the local procedure targeting
the ulcer, the second goal. Local procedures were selected
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around the ulcer (Table I).
Debridement. Surgical debridement of small superfi-
cial ulcers was manually performed by scalpel or sharp
spoon and treated primarily with simple local postsurgical
wound management without grafting.
Shaving. In case of palpable dermatoliposclerosis in-
volving the fascia or, typically, if the ulceration exceeded
2 cm2, shavingwas performedwith an electric shaver (Acculan
Dermatome; Aesculap Ag & Co KG, Tuttlingen, Germany).
The lesion was always covered with a mesh graft or a full-
thickness graft transplantation.
Fasciectomy. En-bloc resection of the ulcer, including
the crural fascia, was performed in case of induration or
palpable calcification. If the muscle was elevated above the
fascial level after that procedure, fasciotomy, a subcutane-
ous longitudinal decision of the crural fascia, was per-
formed.
After surgery, all patients, excluding those with PAD
Fig 2. Schematic diagram of applied surgical procedures of the
veins, illustrating the occurrence and combinations of surgical
techniques. SSV, Short saphenous vein;GSV, great saphenous vein.
The numbers indicate patients who received these (combined)
procedures. Of the 120 surgical interventions of perforators, sub-
fascial endoscopic perforator vein surgery was performed in 12
legs.
Table I. Local procedure for the ulcer
Variable No. legs (n  173)
Surgery for the ulcer
Fasciectomy 57
Shave 31
Debridement 85
Procedure for the defect
Mesh graft transplantation 86
Full-thickness graft transplantation 21
Without graft transplantation 66(30 legs), were treated with compression bandaging(Porelast and Panelast; Lohmann & Rauscher GmbH,
Wien, Austria) lengthwise and lengthwise/widthwise elas-
tic adhesive bandages until healing and afterward with
elastic compression stockings (Sigvaris, No. 702, class II,
30 mm Hg; Ganzoni & Cie AG, St Gallen, Switzerland).
Statistical analyses. Statistical analysis was performed
with SAS (SAS Institute, Cary, NC) and SPSS (SPSS Inc,
Chicago, Ill) software. Patients lost to follow-up were
compared with those attending follow-up by using one-
way analysis of variance and the Tukey post hoc test for
multiple comparisons.
The results for the time of ulcer healing and recurrence
were analyzed with Kaplan-Meier life tables. Furthermore,
Cox regression analysis was used to show the association
between the risk factors of healing time and recurrence
time.
The differences in the outcome for patients with PAD
and those with venous dysfunction of unknown cause and
secondary etiology due to a postthrombotic syndromewere
analyzed with two-by-two contingency tables and Fisher
exact tests. Paired t tests were used to compare the presur-
gical and postsurgical outcome of the Nottingham Health
Profile and visual analogue scale. Finally, Wilcoxon analysis
was used to compare the outcomes of the subjective state of
health evaluated by questionnaires. P .05 was considered
statistically significant.
RESULTS
Presurgical visit
Comparing the patients who did not attend follow-up
and those who were deceased at the time of follow-up, we
identified a significant difference between these groups in
the presence of diabetes (2 test: P  .0001), coronary
artery disease (2 test: P  .0001), and PAD (2 test: P 
.001). Among these three groups, significant differences in
BMI (P  .007) and size of ulceration (P  .001) and no
significant differences (P  .114) in the duration of the
ulcer were identified.
Clinical characteristics before surgery. The duration
of the leg ulcer before the operation ranged from 0.1 to 55
years (median, 5 years). During that time, some ulcers
temporarily healed as a result of different therapies but then
recurred. Before surgery, the patients had been perma-
nently resistant to treatment for a period ranging from 2
weeks to 30 years (median, 1 year).
A total of 66% of the patients had a family history of
varicose veins, deep vein thrombosis, and/or leg ulcers. Of
the group, 36% (n  63) and 29% (n  51%) reported at
least one episode of cellulitis or deep vein thrombosis,
respectively, before the surgical treatment. All tested pa-
tients (95 legs) showed an allergic reaction to the topical
application of ointments, and 28% (49 legs) of the cases
showed a reaction to more than 5 allergens.
The area of ulceration ranged from 0.25 to 500 cm2
(median, 12 cm2). Nine patients had a circumferential
ulcer. In 13% of the cases (23 legs), tendons, bones, and
joints were involved; in 49% (84 legs), the fascia was in-
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stricted to the dermis and subcutis. Wound secretion was
severe in 65% (112 legs) and moderate in 26% (45 legs). All
patients had dermatoliposclerosis, with fascia involved in
69%, which was frequently calcified (40 legs).
Edema was severe in 15% (26 legs), mild in 65% (112),
and moderate in 17% (29 legs). Only 3% (6) had no edema.
According to the CEAP classification at the time of the
operation, all limbs had active ulcers (C6), 68% (118 legs)
had a primary reflux (venous dysfunction of unknown
cause), and 32% (55 legs) had a secondary etiology due to a
postthrombotic syndrome.
Concomitant risk factors. At the time of the opera-
tion, the BMI calculations indicated that 46% were obese,
35% were overweight, 18% were normal weight, and 1%
were underweight (Table II). In addition, 13% had diabe-
tes, with an average duration of 10 years (median, 6 years),
ranging from 1 to 40 years, and 91.9% (159 legs) had
noticeable varicose veins, which had existed in 50% of the
legs for more than 30 years and a maximum of 68 years
(median, 30 years). At the time of operation, 24% of the
patients had coronary heart disease.
In 17% of the cases (30 legs), the ankle-brachial pres-
sure index was less than 0.8 or showed a Mönckeberg
sclerosis (Table III). In terms of ankle mobility, 42% (73
legs) showed free mobility of the ankle joints, 23% (40 legs)
exhibited restricted mobility, and 32% (55 legs) showed
excessively restricted mobility; in 3% (5 legs), the ankle
joint was stiff.
Duplex findings. All patients had venous refluxes, as
shown in Fig 3. The clinical symptoms of the venous leg
ulcer resulted in all cases from a reflux (PR); we did not
attempt to detect obstruction.
Postsurgical follow-up
Clinical outcome. The mean follow-up was 3 years
and ranged from 3 months to 7 years (median, 3.11 years;
SD, 5.22 years). In 1% (two legs), postoperative complica-
tions occurred. These complications included subsegmen-
tal pulmonary embolism in one patient and a hematoma
that needed to be evacuated in another patient.
Complete ulcer healing was defined as a full re-
epithelialization of the wound with an absence of secre-
tions; recurrence was defined as an epithelial breakdown in
the healed limb. Initial ulcer healing was achieved in 87%
(151 legs). Recurrent venous ulcers occurred in 5% (nine
Table II. Risk factor: obesity
BMI at operation (kg/m2) Classification No. legs %
19 Underweight 1 1
19-24.9 Normal 32 18
25-29.9 Overweight 61 35
30 Obese 79 46
BMI, Body mass index.legs; Fig 4).The Kaplan-Meier analyses of ulcer healing for all legs
(Fig 5) showed an 85% healing rate in 6 months. Quartile
estimates showed a healing rate of 75% in 2.3 months. The
mean time of healing was 1.5 months. In addition, the
Kaplan-Meier analyses of ulcer recurrence (Fig 6) showed
for all legs a 1.7% recurrence rate at 6 months. The 5-year
ulcer recurrence rate was 4.6%. The mean time to recur-
rence was 70.4 months.
Assessment of 10 risk factors related to prolonged
healing time and recurrence time showed that healing time
was significantly related to age at the time of the operation
(Table IV). The effect of surgery on ulcer recurrence time
was significantly affected by age and the presence of severe
edema. No other factor showed an effect (Table V).
There was no significant difference in the comparison
(healing and recurrence) between the groups with PAD
(P .999) and those without it. In the case of patients with
and without postthrombotic changes (secondary etiology
due to a postthrombotic syndrome), there also was no
significant difference in the outcome (P .999), as was the
case with patients with or without venous dysfunction of
unknown cause (P  .571).
Duplex findings. Refluxes were identified at follow-
up in 77% (135 legs) of cases, as detailed in Fig 3. The
discrepancy between the different numbers of refluxes can
be explained by the persistence of remnant deep refluxes
combined with recurrent superficial and/or perforating
refluxes after surgery or recovered deep reflux after surgery
of the superficial and/or perforating veins. The group
experiencing deep and perforating reflux (18 legs) at the
time of operation had the highest percentage (seven legs;
39%) of nonhealed ulcers. Refluxes in the perforating veins
were localized in 58% (100 legs). Deep reflux was localized
in 44% (76 legs).
Quality of life. For 120 patients (169 legs), quality-
of-life data were available. Between the preoperative and
postoperative situations, in every dimension of the Not-
tingham Health Profile there was a highly significant out-
come (P  .0001), and there were significantly reduced
levels of pain on the visual analogue scale pain score (P 
.0001). There was also a significant (P  .0001) benefit
from the surgical treatment in terms of the subjective state
of health (Fig 7).
DISCUSSION
As this study shows, there were good short- and long-
Table III. Risk factor: peripheral arterial disease
ABPI No. legs %
0.5 2 1.2
0.5-0.8 26 15.0
0.81-1 13 7.5
1 130 75.1
Mönckeberg sclerosis 2 1.2
ABPI, Ankle-brachial pressure index.term results for all groups, including those with mixed
and it
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up; the deaths were unrelated to surgery, and approxi-
mately half of those who died had prior PAD. Nelzen et al21
documented high death rates of nearly 50% at the 5-year
follow-up for similar groups of patients. Their subgroup
analyses also showed that the poor survival was caused by
higher mortality related to PAD, coronary artery disease,
and diabetes.
Our results demonstrate that surgical methods play an
important role in the management of recalcitrant leg ulcers.
Basically, the surgical therapy has to be adjusted to fit the
type of chronic venous incompetence and the degree of
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The number of primary nonhealed ulcers could have been
lower because deep reflux was present in most. Correction
of reflux of the superficial and perforator system, as shown
in this study, remains useful even with the advent of en-
dovenous laser treatment. We did not include patients
treated with endovenous laser treatment in this study; how-
ever, our experience shows that even though endovenous laser
treatment is an advance in theminimized surgical approach, it
can never fully displace accepted surgical procedures.
In addition, even with SEPS, previously used surgical
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10 15 20
10 15 20
11 2
2
10 15 20
10 15 20
16
2
3
2 1
1
3
10 15 20
Post-surgical
reflux
l reflux. 
d recurrence 
 recurrent 
s+p
n=15
d+p
n=32
d
n=21
s+d
n=10
no
reflux
n=38
s+p+d
n=13
p
n=30
s
n=14
flux cases (s, superficial; p, perforantes; d, deep) and
s healing/recurrence.7
15
1
rgica
ng an
cal reshows, only 12% of perforators were suitable for treatment
JOURNAL OF VASCULAR SURGERY
Volume 44, Number 3 Obermayer et al 577with SEPS, especially in cases of more than one perforator.
SEPS should be considered a minimized approach com-
pared with other surgical techniques and is often not useful
if there is only one perforator.
Our experience showed that a skin graft is necessary
only for big and/or deep ulcers. In cases of small and
superficial ulcers, shaving with a scalpel or a sharp spoon
can impede self-healing without a graft. In cases of large
ulcers combined with induration or calcification, fasciec-
tomy should be performed to remove the defect and help
facilitate short healing times.
Compression bandaging is not advisable in cases of
PAD,23 but surgical therapy concentrating on venous re-
flux is a viable alternative. The current recommended ap-
proach to mixed ulcers is to correct the arterial component
first; for example, Treiman et al24 describe this approach,
which is more likely to achieve satisfactory ulcer healing. As
we determined before surgery, all ulcers included in this
study were caused by venous insufficiency; mixed ulcers
HEALING AND RECURRENCE
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Fig 4. Healing and recurrence rates.
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and time of healing (in years). Deaths are censored.were treated accordingly, and the arterial disease was han-dled as a secondary manifestation. From our point of view,
which the current results emphasize, treatment of the arte-
rial disease is not required for initial healing of the ulcer.
Even in these cases, which will be separately reported in
more detail, surgery was not followed by any complica-
tions.
Some possible complications,25 such as thrombosis or
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Fig 6. Kaplan-Meier analyses of freedom from ulcer recurrence
among surviving patients, including several time points (number of
legs remaining) and time of recurrence (in years). Deaths are
censored.
Table IV. Risk factors related to healing time
Variable P value
Age at operation .0138
Size of ulceration .1176
PAD, index 0.8, and Mönckeberg sclerosis .8116
Reflux in the deep veins, presurgical .3265
Reflux in the deep veins at follow-up .4337
BMI at operation .6936
Duration of ulceration .5646
Mobility of the ankle joint .8977
Presence of severe edema .6228
PAD, Peripheral arterial disease; BMI, body mass index.
Table V. Risk factors related to recurrence
Variable P value
Age at operation .0004
Size of ulceration .8068
PAD, index 0.8, and Mönckeberg sclerosis .3946
Reflux in the deep veins, presurgical .2361
Reflux in the deep veins at follow-up .8922
BMI at operation .1064
Duration of ulceration .2877
Mobility of the ankle joint .6493
Presence of severe edema .0357
PAD, Peripheral arterial disease; BMI, body mass index.iatrogenic lymphedema, did not occur in our patients. The
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the patient to unbearable pain, and we consider it reason-
able to correct venous hemodynamics with the help of
immediate surgery at any state of venous insufficiency.26
Therefore, we propose that surgery should be considered
before the patients are intractable to treatment.27 Those
patients whose causes for venous ulcers are eliminated in
time require no more than surgical intervention of superfi-
cial and perforating veins. The initial healing rate is compa-
rably high at 87%, and the recurrence rate after 5 years is
low (5%), especially with a focus on the outcome of
nonsurgical techniques. Six months after surgery, the
recurrence rate was 1.7%, thus emphasizing the need for
long-term follow-up, which may be difficult in an older
population.6,28 Comparing these results with those from
compression therapy alone, a benefit from surgery can be
shown in both healing time and recurrence. Ennis and
Meneses29 reported that the standard of care for venous leg
ulcers is based on local wound care and application of
compression therapy. Published rates of healing with this
standard of care are between 45% and 83% with 24 weeks of
treatment.30,31 Partsch et al32 found in their multicenter,
randomized controlled trial that total healing rates for
four-layer bandages and short-stretch bandages were 62%
and 73% and that median healing times were 57 and 63
days, respectively. This outcome highlights the fast healing
times after surgical techniques. Regarding low compliance
as a disadvantage of compression therapy,33-35 a reduced
incidence rate of recurrence after surgery can be expected.
Comparing the results of our study with recurrence rates of
nonoperative techniques (reported as 28% and 57% after 2
years36,37 and 38% after 3 years33), ours are quite low and
support the efficacy of surgical techniques.
As Machet et al38 described, the prevalence of sensiti-
physical
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sleepemotional
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painenergy level
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Fig 7. The preoperative (Pre) and postoperative (Post) situation
in every dimension of the Nottingham Health Profile (n  169;
P  .0001).zation is still high in leg ulcer patients. In addition, the100% positive results in all tested persons in our study
suggest a large number of potentially undetected allergies;
however, allergy in patients with leg ulcers is primarily
iatrogenically compromised and makes subsequent treat-
ments, including surgery, more difficult: 21 of 22 non-
healed ulcers in our study were concurrent with allergies. This
result also supports a surgical approach at an early stage.
Analyses of demographic or anatomic factors and their
influence on healing and recurrence also have to be consid-
ered. In concordance with our results, Gohel et al39 found
that patient age and ulcer chronicity were significant risk
factors for recurrence. Danielsson et al40 identified a high
rate of obese patients in their study and described obesity as
a risk factor. The high rate of 81% of overweight and obese
patients in our study confirms this idea.
This study showed that venous surgery is possible and
indicated at any stage, whether years of conservative ther-
apy have failed or whether patients have an ulceration for
only a few weeks. There exists no universal recipe to treat a
leg ulcer. On the basis of detailed diagnosis with duplex
ultrasonography, there are many different surgical proce-
dures with different benefits, and the most pertinent goal is
to determine an individual strategy for every patient. Ran-
domized controlled trials will be indispensable to demon-
strate clearly the superiority of surgery in comparison with
the usual conservative treatment.13
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